Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317)
Condition(s):ChikungunyaLast Updated:July 3, 2023Completed
Hide Studies Not Open or Pending
Condition(s):ChikungunyaLast Updated:July 3, 2023Completed
Condition(s):NorovirusLast Updated:April 1, 2019Completed
Condition(s):Norovirus; Healthy ParticipantsLast Updated:February 22, 2018Completed
Condition(s):Venezuelan Equine Encephalitis; Western Equine Encephalitis; Eastern Equine Encephalitis; Alphavirus InfectionsLast Updated:March 24, 2021Completed
Condition(s):Healthy VolunteersLast Updated:June 10, 2021Completed
Condition(s):Norovirus PreventionLast Updated:August 21, 2017Completed
Condition(s):NorovirusLast Updated:May 18, 2020Completed
Condition(s):Chikungunya VirusLast Updated:July 3, 2023Completed
Condition(s):Cervical Cancers; Vulvar Cancer; Vaginal Cancer; Genital Lesions; PAP Test Abnormalities; HPV InfectionsLast Updated:October 3, 2022Completed
Condition(s):Seasonal InfluenzaLast Updated:July 18, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.